Peripheral blood lymphocyte subsets are associated with the clinical outcomes of prostate cancer patients.

Mao, Fei; Yang, Chao; Luo, Weiyu; Wang, Yijin; Xie, Jie; Wang, Hengbing

Mao, Fei; Yang, Chao; Luo, Weiyu; Wang, Yijin; Xie, Jie; Wang, Hengbing.

Afiliación

Mao F; Department of Urology, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, 1 West Huanghe Road, Huai'an, Jiangsu 223300, China.
Yang C; Department of Urology, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, 1 West Huanghe Road, Huai'an, Jiangsu 223300, China.
Luo W; Department of Urology, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, 1 West Huanghe Road, Huai'an, Jiangsu 223300, China.
Wang Y; Department of Urology, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, 1 West Huanghe Road, Huai'an, Jiangsu 223300, China.
Xie J; Department of Urology, The Fifth People's Hospital of Huaian, Huai'an, China.
Wang H; Department of Urology, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, 1 West Huanghe Road, Huai'an, Jiangsu 223300, China. Electronic address: wanghengbing2004@163.com.

Int Immunopharmacol ; 113(Pt A): 109287, 2022 Dec.

Article en En | MEDLINE | ID: mdl-36252497

Asunto(s)

Neoplasias de la Próstata; Subgrupos de Linfocitos T; Masculino; Humanos; Subgrupos Linfocitarios; Recuento de Linfocitos; Pronóstico

Palabras clave

CD4(+) T cells; Lymphocyte subsets; NK cells; Prostate cancer; Survival

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Subgrupos de Linfocitos T Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Int Immunopharmacol Asunto de la revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google